A glance into the future of anti-neutrophil cytoplasmic antibody-associated vasculitis.

ABSTRACT: In the past decade, unprecedented progress has been made in understanding the pathogenesis, diagnosis, assessment, and treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs). International collaborations and input from several fields (e.g. immunology, rheumatology, and nephrology) have been critical for analyzing demographics, disease manifestations, and outcomes in clinical research studies. Such efforts opened new avenues for generating novel questions and rationale to design better clinical trials. In addition, clinical research has been a source of several biological discoveries and the starting point for knowledge seeking on the pathophysiology of AAV. Interestingly, the blending of clinical and basic research provides a platform for personalized medic

SUBMITTER: Casal Moura M 

PROVIDER: S-EPMC9638684 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature